Ernexa Therapeutics (ERNAW) Debt Ratio (2013 - 2026)

Ernexa Therapeutics has reported Debt Ratio for 14 years, with the latest figure at 0.0 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Mar 2026 stood at 0.0 (changed N/A YoY), and the FY2025 full-year result was 0.01, changed N/A from the prior year.
• Debt Ratio for Q1 2026 stood at 0.0, down from 0.01 in the prior quarter.
• The five-year high for Debt Ratio was 0.64 in Q3 2024, with the low at 0.0 in Q1 2026.
• Historically, Debt Ratio has averaged 0.14 across 5 years, with a median of 0.01 in 2025.
• The largest YoY upside for Debt Ratio was 98.96% in 2025 against a maximum downside of 98.96% in 2025.
• Ernexa Therapeutics' Debt Ratio stood at 0.13 in 2022, then grew by 25.61% to 0.17 in 2023, then jumped by 282.95% to 0.64 in 2024, then slumped by 98.9% to 0.01 in 2025, then slumped by 44.66% to 0.0 in 2026.
• The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.01 (Q4 2025), and 0.01 (Q3 2025), per Business Quant data.